Ovarian clear cell carcinoma
Conditions
Interventions
case group:Nil
Sponsors
Ethics Committee of the First Affiliated Hospital of University of Science and Technology of China
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1. For patients undergoing initial surgery, the postoperative pathology was confirmed by at least 2 physicians above the level of associate chief physician of the pathology department to be OCCC, excluding mixed OCCC; 2. After the initial surgery in the foreign hospital after the diagnosis of OCCC For patients undergoing staged surgery or cytoreductive surgery in the hospital, the pathological slices will be reviewed by at least 2 associate-senior doctors in the pathology department of hospital; 3. Early stage patients undergo standard staging surgery in the hospital, advanced patients received the initial cytoreductive surgery in our hospital; 4. The patient received systemic chemotherapy based on platinum drugs after the operation; 5. The patient and his family fully informed consent to participate in this study.
Exclusion criteria
Exclusion criteria: 1. The patient had received neoadjuvant chemotherapy before the operation; 2. The required research data was not complete; 3. The patient was lost to follow-up within 30 days after the operation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| CA125;HE4;CA19-9;D dimer; | — |
Countries
China
Contacts
Public ContactZhou Ying
The First Affiliated Hospital of University of Science and Technology of China
Outcome results
None listed